Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2005 | CD13 (aminopeptidase N) can associate with tumor- associated antigen L6 and enhance the motility of human lung cancer cells | Chang, Y. W.; Chen, S. C.; Cheng, E. C.; Ko, Y. P.; Kao, Y. R.; Tsai, Y. C.; Chen, S. Y.; Tsay, Y. G.; Yang, P. C.; Wu, C. W.; Roffler, S. R. | Int J Cancer 116, 243-252 | | | |
2005 | CD13 (aminopeptidase N) can Associate with Tumor-Associated Antigen L6 and Enhance the Motility of Human Lung Cancer Cells | Chang, Y. -W.; Chen, S. -C.; Cheng, E. -C.; Ko, Y. -P.; Lin, Y. -C.; Kao, Y. -R.; Tsay, Y. -G.; Yang, P. -C.; Wu, C. -W.; Roffler, S. R. | Int. J. Cancer 116, 243-252 | | | |
2005 | CD13 (aminopeptidase N) can associate with tumor-associated antigen L6 and enhance the motility of human lung cancer cells | Chang, Y. W.; Chen, S. C.; Cheng, E. C.; Ko, Y. P.; Lin, Y. C.; Kao, Y. R.; Tsay, Y. G.; Yang, P. C.; Wu, C. W.; Roffler, S. R. | Int J Cancer 116(2), 243-252 | | | |
1992 | Characterization of a human cervical carcinoma-associated antigen by lectin binding and immuno-electron microscopy | Wang, J. J.; Roffler, S. R.; Yu, M. H.; Chou, S. H.; Cheng, C. H.; Yin, C. S.; Yeh, M. Y. | Histochem 97, 453-461 | | | |
2000 | Characterization of a tumor-specific antigen expressing on Chang hepatoma ascites cells | Lin, S. C.; Roffler, S. R.; Cheng, T. L.; Chang, K. T.; Chang, J. P.; Wang, J. J. | Acta Histochemica et Cytochemica 33, 367-375 | | | |
1999 | Characterization of an antineoplastic glucuronide prodrug | Cheng, T. L.; Chou, W. C.; Chen, B. M.; Chern, J. W.; Roffler, S. R. | Biochem Pharmacol 58, 325-328 | | | |
2004 | Chimeric protein and method of controlling tumor growth using the protein | Roffler, S. R.; Liao, K. W. | US Patent 6,699,972 | | | |
2006 | Combination cancer therapy by hapten-targeted prodrug-activating enzymes and cytokines | Chuang, K. H.; Cheng, C. M.; Roffler, S. R.; Lu, Y. L.; Lin, S. R.; Wang, J. J.; Tzou, W. S.; Su, Y. C.; Chen, B. M.; Cheng, T. L. | Bioconjugate Chem 17, 707-714 | | | |
2007 | Combination of tumor site-located CTL-associated antigen-4 blockade and systemic regulatory T-cell depletion induces tumor destructive immune responses | Tuve, S.; Chen, B. M.; Liu, Y.; Cheng, T. L.; Toure, P.; Sow, P. S.; Feng, Q.; Kiviat, N.; Strauss, R.; Ni, S.; Li, Z. Y.; Roffler, S. R.; Lieber, A. | Cancer Research 67(12), 5929-5939 | | | |
1997 | Cure of malignant ascites and generation of protective immunity by monoclonal antibody-targeted activation of a glucuronide prodrug in rats | Chen, B. M.; Chan, L. Y.; Wang, S. M.; Wu, M. F.; Chern, J. W.; Roffler, S. R. | Int J Cancer 73, 392-402 | | | |
1995 | Cytotoxicity and antimicrobial activity of some naphthol derivatives | Shen, A. Y.; Hwang, M. H.; Roffler, S. R.; Chen, C. F. | Archiv Der Pharmazie 328, 197-201 | | | |
1988 | Design and mathematical description of differential contactors used in extractive fermentation | Roffler, S. R.; Blanch, H. W.; Wilke, C. R. | Biotechnol Bioeng 32, 192-204 | | | |
1999 | Design and synthesis of water-soluble glucuronide derivatives of camptothecin for cancer prodrug monotherapy and antibody-directed enzyme prodrug therapy (ADEPT) | Leu, Y. L.; Roffler, S. R.; Chern, J. W. | J Med Chem 42, 3623-3628 | | | |
2001 | Design of transgenes for efficient expression of active chimeric proteins on mammalian cells | Liao, K. W.; Chou, W. C.; Lo, Y. C.; Roffler, S. R. | Biotechnology and Bioengineering 73, 313-323 | | | |
1997 | Detection of alpha fetoprotein-expressing cells in the blood of patients with hepatoma and hepatitis | Jiang, S. Y.; Shyu, R. Y.; Huang, M. F.; Tang, H. S.; Young, T. H.; Roffler, S. R.; Chiou, Y. S.; Yeh, M. Y. | British Journal of Cancer 75, 928-933 | | | |
1992 | Doxorubicin: monoclonal antibody conjugate for therapy of human cervical carcinoma | Yeh, M. Y.; Roffler, S. R.; Yu, M. H. | Int J Cancer 51, 274-282 | | | |
2007 | Effect of pH and human serum albumin on the cytotoxicity of a glucuronide prodrug of 9-aminocamptothecin | Prijovich, Z. M.; Leu, Y. L.; Roffler, S. R. | Cancer Chemother Pharmacol 60, 7-17 | | | |
2000 | Efficient clearance of poly(ethylene glycol)-modified immunoenzyme with anti-PEG monoclonal antibody for prodrug cancer therapy | Cheng, T. L.; Chen, B. M.; Chern, J. W.; Wu, M. F.; Roffler, S. R. | Bioconjugate Chemistry 11, 258-266 | | | |
2000 | Elevated topoisomerase I activity in cervical cancer as a target for chemoradiation therapy | Chen, B. M.; Chen, J. Y.; Kao, M.; Lin, J. B.; Yu, M. H.; Roffler, S. R. | Gynecol Oncol 79, 272-280 | | | |
2002 | Enzyme-activated Prodrug Therapy Enhances Tumor-specific Replication of Adenovirus Vectors | Bernt, K. M.; Steinwaerder, D. S.; Ni, S.; Li, Z. Y.; Roffler, S. R.; Lieber, A. | Cancer Res 62, 6089-6098 | | | |